SSH - DANVILLE — History
CCN 392047 | 3-year financial timeline | COVID resilience: 16/100
🛡️ Public data only — no PHI permitted on this instance.
$10M
Latest Revenue (FY2022)
-18.6%
Revenue CAGR (3yr)
-13.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $15M | $14M | $10M | -31.1% | -18.6% |
| Operating Expenses | $13M | $12M | $11M | -7.2% | -6.8% |
| Operating Margin | 13.4% | 15.6% | -13.6% | -187.0% | +0.0% |
| Net Income | $2M | $2M | $-1M | -160.0% | +0.0% |
| Licensed Beds | 30 | 30 | 30 | +0.0% | +0.0% |
| Total Patient Days | 8,394 | 7,727 | 5,797 | -25.0% | -16.9% |
| Medicare Day % | 52% | 39% | 53% | +35.1% | +0.6% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 16/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -33.8% ($15M → $10M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-18.6%
This Hospital
+7.6%
State Avg
Latest Margin
-13.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $7M | -27.1% |
| FY2024 (proj) | $5M | -40.6% |
| FY2025 (proj) | $2M | -54.1% |